JACOB LEONARD S
Insider CIK 1049713 · AIS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 73,431 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 123,860 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 198,789 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 300,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 160,636 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 60,407 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 77,662 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 153,097 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer | 2022-05-24 | 2022-05-26 | 31,674 | $5.60 | $177.4K | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer | 2022-05-24 | 2022-05-26 | 138,901 | $5.60 | $777.8K | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2021-08-27 | 2021-08-31 | 24,679 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2021-08-27 | 2021-08-31 | 13,820 | $4.00 | $55.3K | 295,575 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2021-08-27 | 2021-08-31 | 24,679 | $2.24 | $55.3K | 309,395 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2021-06-10 | 2021-06-14 | 60,407 | — | $0 | 60,407 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2021-06-10 | 2021-06-14 | 31,674 | $4.42 | $140.0K | 284,716 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2021-02-18 | 2021-02-19 | 15,321 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2021-02-18 | 2021-02-19 | 15,321 | $2.24 | $34.3K | 268,363 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2021-02-18 | 2021-02-19 | 15,321 | $5.05 | $77.4K | 253,042 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2020-06-11 | 2020-06-15 | 77,662 | — | $0 | 77,662 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2020-06-11 | 2020-06-15 | 40,293 | $2.73 | $110.0K | 253,042 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2019-12-09 | 2019-12-11 | 80,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2019-12-09 | 2019-12-11 | 80,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2019-12-09 | 2019-12-11 | 84,814 | $4.63 | $392.7K | 212,749 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2019-12-09 | 2019-12-11 | 80,000 | $1.66 | $132.8K | 377,563 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2019-12-09 | 2019-12-11 | 80,000 | $4.62 | $369.6K | 297,563 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2019-12-09 | 2019-12-11 | 80,000 | $4.63 | $370.4K | 297,563 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2019-12-09 | 2019-12-11 | 80,000 | $1.60 | $128.0K | 377,563 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2019-10-31 | 2019-11-04 | 20,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2019-10-31 | 2019-11-04 | 20,000 | $1.10 | $22.0K | 297,563 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2019-06-13 | 2019-06-14 | 73,431 | — | $0 | 73,431 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2019-06-13 | 2019-06-14 | 37,671 | $2.92 | $110.0K | 277,563 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2019-04-08 | 2019-04-10 | 30,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2019-04-08 | 2019-04-10 | 62,078 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2019-04-08 | 2019-04-10 | 62,078 | $0.53 | $32.9K | 301,970 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2019-04-08 | 2019-04-10 | 92,078 | $3.00 | $276.2K | 239,892 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2019-04-08 | 2019-04-10 | 30,000 | $0.53 | $15.9K | 331,970 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2018-06-08 | 2018-06-11 | 153,097 | — | $0 | 153,097 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2018-03-29 | 2018-04-02 | 32,407 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2018-03-29 | 2018-04-02 | 32,407 | $0.85 | $27.5K | 239,892 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2017-10-09 | 2017-10-11 | 30,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2017-10-09 | 2017-10-11 | 188,600 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2017-10-09 | 2017-10-11 | 30,000 | $4.05 | $121.5K | 218,885 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2017-10-09 | 2017-10-11 | 30,000 | $0.85 | $25.5K | 248,885 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2017-10-09 | 2017-10-11 | 200,000 | $4.05 | $810.0K | 207,485 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2017-10-09 | 2017-10-11 | 188,600 | $0.50 | $94.3K | 407,485 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2017-06-07 | 2017-06-09 | 160,636 | — | $0 | 160,636 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2017-04-04 | 2017-04-05 | 21,762 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2017-04-04 | 2017-04-05 | 21,762 | $1.65 | $35.9K | 240,647 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2017-04-04 | 2017-04-05 | 21,762 | $2.90 | $63.1K | 218,885 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2017-04-03 | 2017-04-05 | 20,000 | — | $0 | 21,762 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2017-04-03 | 2017-04-05 | 20,000 | $1.65 | $33.0K | 238,885 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2017-04-03 | 2017-04-05 | 20,000 | $2.88 | $57.6K | 218,885 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2016-12-01 | 2016-12-05 | 20,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2016-12-01 | 2016-12-05 | 20,000 | $1.97 | $39.4K | 218,885 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2016-12-01 | 2016-12-05 | 20,000 | $1.23 | $24.6K | 238,885 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2016-06-02 | 2016-06-06 | 300,000 | — | $0 | 300,000 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | P Buy | 2016-03-18 | 2016-03-21 | 50,000 | $0.72 | $36.0K | 218,885 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2015-05-28 | 2015-06-01 | 198,789 | — | $0 | 198,789 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2015-03-23 | 2015-03-24 | 19,100 | $2.68 | $51.2K | 168,885 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2015-03-20 | 2015-03-24 | 4,400 | $2.69 | $11.8K | 187,985 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | P Buy | 2014-08-11 | 2014-08-12 | 10,000 | $1.98 | $19.8K | 192,385 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2014-05-29 | 2014-06-02 | 123,860 | — | $0 | 748,707 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2014-01-15 | 2014-01-17 | 11,400 | — | $0 | 624,847 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2014-01-15 | 2014-01-17 | 11,400 | $0.50 | $5.7K | 138,229 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2014-01-15 | 2014-01-17 | 11,400 | $5.05 | $57.6K | 126,829 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2013-05-22 | 2013-05-24 | 55,556 | — | $0 | 182,385 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2013-05-17 | 2013-05-21 | 17,000 | $4.00 | $68.0K | 126,829 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | P Buy | 2012-11-16 | 2012-11-16 | 10,000 | $3.44 | $34.4K | 82,000 | SEC↗ |
| AIS ANTARES PHARMA, INC. | A Award | 2012-05-17 | 2012-05-21 | 61,829 | — | $0 | 133,829 | SEC↗ |